Skip to search formSkip to main contentSkip to account menu

CEP-28122

National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

BenzocycloheptenesPyrimidines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Abstract 3574: Identification and preclinical characterization of CEP-28122, a highly potent and selective orally active inhibitor of anaplastic lymphoma kinase, in lymphoma and non-small cell lung…
Anaplastic lymphoma kinase (ALK) was originally identified as the oncogenic NPM (nucleophosmin)-ALK fusion protein due to a t (2… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)